These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 9316585)

  • 1. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
    Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
    Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Acetylaminofluorene-mediated alteration in the level of liver arylsulfotransferase IV during rat hepatocarcinogenesis.
    Ringer DP; Norton TR; Howell BA
    Cancer Res; 1990 Sep; 50(17):5301-7. PubMed ID: 2386938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a complementary DNA for rat liver aryl sulfotransferase IV and use in evaluating the hepatic gene transcript levels of rats at various stages of 2-acetylaminofluorene-induced hepatocarcinogenesis.
    Yerokun T; Etheredge JL; Norton TR; Carter HA; Chung KH; Birckbichler PJ; Ringer DP
    Cancer Res; 1992 Sep; 52(17):4779-86. PubMed ID: 1511441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of hepatic mRNA translation activity and specific expression of arylsulfotransferase IV during acetylaminofluorene-induced rat hepatocarcinogenesis.
    Yerokun T; Norton TR; Howell B; Ringer DP
    Cancer Res; 1991 Jan; 51(2):504-9. PubMed ID: 1670761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated concentrations of serum alpha-fetoprotein in rats with chemically induced liver tumors.
    Kroes R; Sontag JM; Sell S; Williams GM; Weisburger JH
    Cancer Res; 1975 May; 35(5):1214-7. PubMed ID: 47266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of two separate mechanisms for the decrease in aryl sulfotransferase activity in rat liver during early stages of 2-acetylaminofluorene-induced hepatocarcinogenesis.
    Ringer DP; Howell BA; Norton TR; Woulfe GW; Duffel MW; Kosanke SD
    Mol Carcinog; 1994 Jan; 9(1):2-9. PubMed ID: 8297481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute or chronic treatment of rats with N-2-fluorenylacetamide on its N-hydroxylation and on hemoproteins of hepatic microsomes.
    Malejka-Giganti D; Ritter CL
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):53-64. PubMed ID: 7394317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development.
    Katayama S; Ohmori T; Maeura Y; Croci T; Williams GM
    J Natl Cancer Inst; 1984 Jul; 73(1):141-9. PubMed ID: 6588222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the binding of N-2-fluorenylacetamide to specific regions of the hepatic genome in vivo in rats.
    Schwartz EL; Braselton WE; Goodman JI
    J Natl Cancer Inst; 1981 Apr; 66(4):667-72. PubMed ID: 6939914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression.
    Chakraborty T; Chatterjee A; Rana A; Srivastawa S; Damodaran S; Chatterjee M
    Life Sci; 2007 Jul; 81(6):489-99. PubMed ID: 17651763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of hepatic sulfotransferases by steroidal chemicals in rats.
    Liu L; Klaassen CD
    Drug Metab Dispos; 1996 Aug; 24(8):854-8. PubMed ID: 8869819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide.
    Williams GM; Furuya K
    Carcinogenesis; 1984 Feb; 5(2):171-4. PubMed ID: 6697434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene.
    Maeura Y; Weisburger JH; Williams GM
    Cancer Res; 1984 Apr; 44(4):1604-10. PubMed ID: 6704970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of Vitamin E pre-treatment on N-nitrosodiethylamine induced oxidative stress in rat liver.
    Bansal AK; Bansal M; Soni G; Bhatnagar D
    Chem Biol Interact; 2005 Oct; 156(2-3):101-11. PubMed ID: 16144695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolite profile in milk of lactating rats after treatment with a carcinogen, N-2-fluorenylacetamide.
    Malejka-Giganti D; Magat WJ; Adelmann AM; Decker RW
    Drug Metab Dispos; 1987; 15(6):760-6. PubMed ID: 2893699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting activities of the C-9 oxidized metabolites of N-2-fluorenylacetamide in liver carcinogenesis in the rat.
    Vijayaraghavan P; Malejkagiganti D; Shinozuka H
    Int J Oncol; 1995 Aug; 7(2):287-94. PubMed ID: 21552838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.